Israeli COVID-19 Vaccine Developments Webinar

Actions and Detail Panel

Sales Ended

Event Information

Share this event

Date and time

Location

Location

Online event

Event description
Israel's Campaign to Cure the Coronavirus

About this event

Wednesday, May 6, 12:00-1:00pm EST, 19:00-20:00 Israel time

The world awaits a coronavirus cure. Might it come from The Startup Nation? Learn how Israel has mobilized its scientific and technological talents to overcome this modern-day plague, featuring:

• Yaky Yanai, CEO of Pluristem Therapeutics (NASDAQ: PSTI) is working on a placenta-based cell therapy treatment for respiratory and inflammatory complications associated with COVID-19.

• Vered Kaplan, CEO of Orgenesis, (NASDAQ: ORGS) a global biotech company, is unlocking the potential of cell and gene therapy including anti-viral technologies relevant for COVID-19 to provide life changing personalized medical treatments at the point-of-care to patients.

• Dr. Mark Levitt, Medical Director from RedHill Biopharma (Nasdaq: RDHL) a specialty biopharmaceutical company, is working on an experimental drug, Opaganib, which has shown anti-viral and anti-inflammatory properties to help reduce lung inflammation in COVID-19 patients.

Zoom information will be given upon registration. For more information contact, bbogage@marylandisrael.org.

Date and time

Location

Online event

Organizer Maryland/Israel Development Center

Organizer of Israeli COVID-19 Vaccine Developments Webinar

The Maryland/Israel Development Center is a non-profit membership organization that promotes bi-lateral trade and economic development. It is a “public-private partnership” of the Maryland Department of Commerce, Israel's Ministry of Economy, and The Associated: Jewish Community Federation of Baltimore. To join the MIDC, go to www.MarylandIsrael.org/membership.


Save This Event

Event Saved